Janssen Research & Development, LLC (Janssen) today announced longer follow-up of up to four years from the pivotal Phase 3 RESONATE™ trial (PCYC-1112) of IMBRUVICA® (ibrutinib) vs. ofatumumab...

MabVax Therapeutics Holdings, Inc. (Nasdaq: MBVX), is a clinical-stage biotechnology company with a fully human antibody discovery platform focused on the rapid translation into clinical...

Long-term follow-up results from the pivotal Phase 3 RESONATE™ trial (PCYC-1112) showed continued survival rates in patients with relapsed/refractory (R/R) chronic lymphocytic leukemia/small...

Microsemi Corporation (Nasdaq: MSCC), a leading provider of semiconductor solutions differentiated by power, security, reliability and performance, today announced a new family of wideband plastic...

Bruker is show-casing several new and innovative, high-performance mass spectrometry solutions for metabolomics, proteoform profiling and toxicology at ASMS 2017 (www.asms.org). Bruker is also...